SCHEMBL20205629

SCHEMBL20205629

CC1(C)c2cc3c(cc2-c2c1cc(-c1ccc(-c4ccc5c(c4)oc4ccccc45)cc1)c1oc4ccccc4c21)C(C)(C)c1cc(-c2ccc(-c4ccc5c(c4)oc4ccccc45)cc2)c2oc4ccccc4c2c1-3

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP12 P39900 1/20 0.37
▸ MMP13 P45452 1/20 0.37
▸ PGR P06401 2/20 0.36
▸ AHR P35869 2/20 0.35
▸ PRKDC P78527 1/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ MAPT P10636 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ ALOX5 P09917 1/20 0.34
▸ HCRTR1 O43613 1/20 0.33
▸ CDC14B O60729 2/20 0.33
▸ CDC14A Q9UNH5 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ PLA2G2A P14555 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205647 0.95 ALOX5 (0.38) MMP12MMP13PGRAHRPRKDC
SCHEMBL20205631 0.93 ALOX5 (0.36) MMP12MMP13PGRAHRPRKDC
SCHEMBL20205378 0.92 CDC14B (0.38) PGRMEN1MAPTKMT2AHPGD
SCHEMBL20205295 0.91 PRKDC (0.35) MMP12MMP13PGRAHRPRKDC
SCHEMBL20205395 0.91 PGR (0.36) MMP12MMP13PGRAHRPRKDC
SCHEMBL20205623 0.89 PRKDC (0.34) MMP12MMP13PGRAHRPRKDC
SCHEMBL20205335 0.89 CDC14B (0.40) PGRMEN1MAPTKMT2AKDM4E
SCHEMBL20205741 0.87 CDC14B (0.36) PGRMEN1MAPTKMT2AHPGD
SCHEMBL20205333 0.87 PLA2G2A (0.36) PGRPRKDCMEN1MAPTKMT2A
SCHEMBL20205632 0.87 PRKDC (0.36) PGRPRKDCMAPTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND MMP12 3834/4885MMP13 4147/4885PGR 4271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback